Treating Drug-Resistant Childhood Schizophrenia

Completed · Phase 4

Conditions studied: Schizophrenia

In brief

This study will compare clozapine and olanzapine (Zyprexa®) for the treatment of children and adolescents who have failed standard antipsychotic treatment for schizophrenia.

Key facts

Study ID

NCT00048828

Run by

Northwell Health

People needed

41

Starts

2001-10-01

Expected to finish

2006-06-01

Last updated by the study team

2013-07-02

Who can join

Age: 10 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• DSM-IV criteria for treatment-refractory schizophrenia or schizoaffective disorder
• Willingness to use an acceptable form of birth control, if applicable

You may not qualify if…

• Neurological or medical disorders that would contraindicate treatment with clozapine or olanzapine
• IQ less than 70
• DSM-IV criteria for substance (other than caffeine or nicotine) related disorder
• Failure of an adequate trial of olanzapine or clozapine

Where it is running

• Sagamore Children's Psychiatric Center — Dix Hills, New York, United States
• Long Island Jewish Medical Center — Glen Oaks, New York, United States
• Bronx Children's Psychiatric Center — The Bronx, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.